Synergistic targeted inhibition of MEK and dual PI3K/ mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.
Saved in:
| Title: | Synergistic targeted inhibition of MEK and dual PI3K/ mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. |
|---|---|
| Authors: | Wei, Bih‐Rong1,2, Michael, Helen T.1, Halsey, Charles H.C.1, Peer, Cody J.3, Adhikari, Amit2,4, Dwyer, Jennifer E.1, Hoover, Shelley B.1, El Meskini, Rajaa2,4, Kozlov, Serguei2,4, Weaver Ohler, Zoe2,4, Figg, William. D.3, Merlino, Glenn1, Simpson, R. Mark1 ms43b@nih.gov |
| Source: | Pigment Cell & Melanoma Research. Nov2016, Vol. 29 Issue 6, p643-655. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17551471 |
|---|---|
| DOI: | 10.1111/pcmr.12512 |
